MSR64 Psychometric Validation of the Electronic Hidradenitis Suppurativa Quality of Life (eHiSQOL) Questionnaire Using Pooled Data from the Phase 3 BE HEARD Trials of Bimekizumab in Hidradenitis Suppurativa
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.1599
https://www.valueinhealthjournal.com/article/S1098-3015(23)01699-6/fulltext
Section Title :
Section Order :
10992
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01699-6&doi=10.1016/j.jval.2023.03.1599